Tandem Diabetes Care, Inc. (TNDM) short interest & options flow
NASDAQTandem Diabetes Care arrives at the end of September with short sellers adding pressure, analysts cutting targets, and the stock down 27% from where it printed Q2 results in August. Short interest is the clearest signal of mounting scepticism. At 18.9% of free float, it has climbed 9% over the past week and nearly 19% over the past month, a build that tracks almost exactly with the…
TNDM short interest surges 34% in a week to 19% of float, driven by mounting bearish sentiment on earnings disappointment and competitive headwinds.
- Market cap
- $1.18B
- Next earnings
- 24 Feb 2027
Key data as of 7 Nov 2026
Latest signals on TNDM
- Short Interest
TNDM short interest surges 34% in a week to 19% of float, driven by mounting bearish sentiment on earnings disappointment and competitive headwinds.
- Options
TNDM put/call ratio spikes to 1.17, highest in 52 weeks, signaling extreme bearish options positioning ahead of May 20 earnings.
- Cost to Borrow
TNDM cost to borrow jumped to 0.41%, up 145% from a week ago.
TNDM news and analysis
RSSNo long-form analysis yet for TNDM. Pulse alerts and the live data picture are available on ORTEX.
Open TNDM on ORTEX →Want the live picture for TNDM?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TNDM — free to start on ORTEX.
Sign up for free →Open TNDM on ORTEX